Air Sanitation Manufacturer AeroClean Technologies Prices US$25 Million IPO

Pathogen elimination technology company AeroClean Technologies, Inc. (Nasdaq: AERC) started publicly trading on the Nasdaq Capital Market today. The firm’s initial public offering is looking to raise US$25 million.

The offering will be conducted through the issuance of 2.5 million common shares selling at US$10.00 per share.

The Benchmark Company, HCFP/Capital Markets, and Valuable Capital Limited are all acting as joint bookrunners for the said offering.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The firm relayed that net proceeds from the offering are expected to be used on supporting the build-out of its organization, funding its air purification devices production, establishing a consumables and services business, and supporting its product development efforts.

The company manufactures air sanitation products and provides anti-pathogen solutions. Its flagship product Pūrgo is developed with a proprietary technology designed by aerospace engineers and medical scientists.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Everybody Should Own Gold | George Bee – U.S. Gold Corp.

A $40M Company Created $2B in Mining Value | John-Mark Staude – Riverside Resources

The Debt Crisis Is Turning Gold Into Money | Shawn Khunkhun – Contango Silver and Gold

Recommended

Power Metallic Starts PEA on Lion and Nisk Main Deposits, Eyes First Half 2027 Completion

Cambria Gold Targets Q4 2027 Mill Restart at Premier as Red Mountain Road Clears Final Permit

Related News

Colombian Mining Firm Mineros Closes US$20 Million IPO, Starts Trading On TSX

Latin American gold mining company Mineros S.A. (TSX: MSA) closed on Friday its initial public...

Monday, November 22, 2021, 02:17:00 PM

Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq...

Tuesday, January 4, 2022, 02:36:00 PM

A Leaked Anthropic Prospectus Shows Explosive Growth, A Widening Loss, and Its Own AI Risk Warnings

A confidential Anthropic prospectus leaked to Reuters shows a company spending as fast as it's...
Tuesday, September 29, 2026, 02:14:53 AM

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq...

Friday, July 9, 2021, 09:53:00 AM

Circle Files for U.S. IPO to Bring Stablecoin USDC to Public Markets

Boston-based Circle Internet Financial, the driving force behind the widely-used stablecoin USDC, has confidentially filed...

Thursday, January 11, 2024, 09:29:00 AM